Natura Cosmeticos S.A. (NATU3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026
Key indicators
| Last close | BRL 7.050 |
|---|---|
| 52-week range | 6.420 – 11.150 |
| Return, 1 month / 3 months | −11.0% / −17.5% |
| Return, 1 year / 3 years | −16.1% / −51.5% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 47.0% |
| Worst drawdown (1 year) | -38.8% |
| Average daily value traded | 65.06M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Natura Cosmeticos is a Brazilian cosmetics and personal care company based in Brazil. It develops and markets skin care, hair care, fragrance, soap and makeup products, drawing on ingredients from Brazilian biodiversity. Its goods reach customers largely through a direct-selling network of independent consultant representatives, alongside retail and digital channels, serving consumers in Brazil and other Latin American markets. The company also operates in personal care and beauty segments through related brands in its home region.
The shares are listed on the Sao Paulo Exchange in Brazil under the code NATU3, and the price on this page is in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Natura Cosmeticos S.A. (NATU3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 7.050 on 16 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 1,099 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.1% and over the last three months it fell 17.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.5% | ||
| From 52-week high | -34.1% | ||
| Momentum | 19 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.5% | ||
| 6-month return | -30.2% | ||
| 12-month return, skipping the last month | -5.7% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 47.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.8% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 65.06M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −4.3% |
|---|---|
| 1 month | −11.0% |
| 3 months | −17.5% |
| 6 months | −30.2% |
| 1 year | −16.1% |
| 3 years | −51.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 7.923 / 8.756 |
|---|---|
| Golden / death cross (60 days) | Death, 56 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.369 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Nov 2019 | BRL 0.1279 |
| 27 Feb 2019 | BRL 0.1315 |
| 7 Jan 2019 | BRL 0.2587 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.